IRADIMED CORPORATION Net Cash Provided by (Used in) Continuing Operations
IRADIMED CORPORATION (IRMD) reported Net Cash Provided by (Used in) Continuing Operations of -$257.23 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-05.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2017-05-05
- IRADIMED CORPORATION net cash provided by (used in) continuing operations for the quarter ending 2017-03-31 was -$257.23K.
- IRADIMED CORPORATION net cash provided by (used in) continuing operations for the quarter ending 2016-12-31 was $1.71M, a 55.46% decline year-over-year.
- IRADIMED CORPORATION net cash provided by (used in) continuing operations for the quarter ending 2016-09-30 was $3.94M, a 26.97% increase year-over-year.
- IRADIMED CORPORATION net cash provided by (used in) continuing operations for the quarter ending 2016-06-30 was -$3.44M, a 308.07% decline year-over-year.
- IRADIMED CORPORATION net cash provided by (used in) continuing operations for fiscal 2016 was -$1.65M, a 116.69% decline from fiscal 2015.
- IRADIMED CORPORATION net cash provided by (used in) continuing operations for fiscal 2015 was $9.91M, a 41.78% increase from fiscal 2014.
- IRADIMED CORPORATION net cash provided by (used in) continuing operations for fiscal 2014 was $6.99M, a 814.96% increase from fiscal 2013.
- IRADIMED CORPORATION net cash provided by (used in) continuing operations for fiscal 2013 was $764.25K.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$257.23K 10-Q · filed 2017-05-05 | $1.45M derived: sum of 2 quarters · filed 2017-05-05 | $5.39M derived: sum of 3 quarters · filed 2017-05-05 | $1.95M derived: sum of 4 quarters · filed 2017-05-05 |
| 2016-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $5.65M derived: sum of 2 quarters · filed 2017-03-10 | $2.21M derived: sum of 3 quarters · filed 2017-03-10 | -$1.65M 10-K · filed 2017-03-10 |
| 2016-09-30 | $3.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $496.63K derived: sum of 2 quarters · filed 2016-11-04 | -$3.36M 10-Q · filed 2016-11-04 | $474.83K derived: sum of 4 quarters · filed 2017-05-05 |
| 2016-06-30 | -$3.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$7.30M 10-Q · filed 2016-08-05 | -$3.46M derived: sum of 3 quarters · filed 2017-05-05 | -$361.67K derived: sum of 4 quarters · filed 2017-05-05 |
| 2016-03-31 | -$3.86M 10-Q · filed 2017-05-05 | -$21.80K derived: sum of 2 quarters · filed 2017-05-05 | $3.08M derived: sum of 3 quarters · filed 2017-05-05 | $4.73M derived: sum of 4 quarters · filed 2017-05-05 |
| 2015-12-31 | $3.84M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $6.94M derived: sum of 2 quarters · filed 2017-03-10 | $8.59M derived: sum of 3 quarters · filed 2017-03-10 | $9.91M 10-K · filed 2017-03-10 |
| 2015-09-30 | $3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $4.76M derived: sum of 2 quarters · filed 2016-11-04 | $6.08M 10-Q · filed 2016-11-04 | -$2.58M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-06-30 | $1.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $2.97M 10-Q · filed 2016-08-05 | -$5.69M derived: sum of 3 quarters · filed 2017-03-10 | $8.17M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-03-31 | $1.32M 10-Q · filed 2016-05-06 | -$7.34M derived: sum of 2 quarters · filed 2017-03-10 | $6.51M derived: sum of 3 quarters · filed 2017-03-10 | $7.86M derived: sum of 4 quarters · filed 2017-03-10 |
| 2014-12-31 | -$8.66M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $5.19M derived: sum of 2 quarters · filed 2017-03-10 | $6.55M derived: sum of 3 quarters · filed 2017-03-10 | $6.99M 10-K · filed 2017-03-10 |
| 2014-09-30 | $13.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $15.21M derived: sum of 2 quarters · filed 2015-11-10 | $15.65M 10-Q · filed 2015-11-10 | $16.07M derived: sum of 4 quarters · filed 2015-11-10 |
| 2014-06-30 | $1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $1.80M 10-Q · filed 2015-08-11 | $2.22M derived: sum of 3 quarters · filed 2015-08-11 | $2.10M derived: sum of 4 quarters · filed 2015-08-11 |
| 2014-03-31 | $447.08K 10-Q · filed 2015-05-11 | $865.65K derived: sum of 2 quarters · filed 2015-05-11 | $746.05K derived: sum of 3 quarters · filed 2015-05-11 | |
| 2013-12-31 | $418.57K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | $298.96K derived: sum of 2 quarters · filed 2015-03-23 | $764.25K 10-K · filed 2015-03-23 | |
| 2013-09-30 | -$119.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $345.68K 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $465.29K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |